Diligence memo · auto-generated · as of July 2, 2026

Enject Inc

Enject Inc looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Enject Inc operates in Other Health Care, based in Battle Ground.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Enject Inc has raised $1.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $1.0M on 2009-09-04.

Most recent recorded round closed around 2009-09-04.

Valuation (modeled)modeled

Provath models Enject Inc at approximately $31M (range $627K–$349M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 2.99× the median modeled value of Pre-Seed Other Health Care companies in 2007–2009 (128 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Last raise 16.8 yr ago; this sector typically re-raises about every 14 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 35% of Other Health Care peers (5376 compared).

Modeled value ranks above 59% of those peers.

Closest niche peers: Active Day, Inc., Aspyra Inc, Sutter Fairfield Surgery Center, LLC, Explainmysurgery.Com, Ortho Neuro Management LLC.

Peoplefiled

5 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.